| __timestamp | Bio-Techne Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 357763000 | 2819557000 |
| Thursday, January 1, 2015 | 452246000 | 4103728000 |
| Friday, January 1, 2016 | 499023000 | 4860427000 |
| Sunday, January 1, 2017 | 563003000 | 5872227000 |
| Monday, January 1, 2018 | 642993000 | 6710800000 |
| Tuesday, January 1, 2019 | 714006000 | 7863400000 |
| Wednesday, January 1, 2020 | 738691000 | 8497100000 |
| Friday, January 1, 2021 | 931032000 | 16071700000 |
| Saturday, January 1, 2022 | 1105599000 | 12172900000 |
| Sunday, January 1, 2023 | 1136702000 | 13117200000 |
| Monday, January 1, 2024 | 1159060000 | 14202000000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Bio-Techne Corporation have showcased contrasting trajectories. From 2014 to 2023, Regeneron has seen its revenue soar by over 365%, peaking in 2021 with a staggering 16 billion dollars. This growth reflects its strategic innovations and market expansions. In contrast, Bio-Techne's revenue has grown steadily, increasing by approximately 222% over the same period, reaching just over 1.1 billion dollars in 2023. While Regeneron's revenue experienced a slight dip in 2022, Bio-Techne continued its upward trend, highlighting its resilience in a competitive market. As we look to the future, the absence of 2024 data for Regeneron leaves room for speculation on its next strategic move.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Examining Key Revenue Metrics
AbbVie Inc. vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Breaking Down Revenue Trends: United Therapeutics Corporation vs Bio-Techne Corporation
Dr. Reddy's Laboratories Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Bio-Techne Corporation vs Telix Pharmaceuticals Limited
Revenue Insights: Bio-Techne Corporation and HUTCHMED (China) Limited Performance Compared
Bio-Techne Corporation and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis